Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pre-Competitive Collaboration Would Help Pharmaceutical Productivity Crisis - If Lawyers Could Get Out Of The Way

This article was originally published in PharmAsia News

Executive Summary

CAMBRIDGE, Mass. - Greater R&D collaboration was the theme of the day at the star-studded U.S.-India Chamber of Commerce biopharma and healthcare summit

You may also be interested in...



BioAsia 2015: Can India Move Beyond Its Low-cost Advantage?

Drug discovery partnerships in India are at the cusp of big changes. Global innovators have moved away from considering India as a low-cost destination, instead looking beyond just outsourcing clinical development projects or in-licensing compounds. They are keen to forge long-term relationships with academia and also to look at model start-ups to spur a culture of innovation.

Emerging Company In An Emerging Market: Generon Sees Quality And Price As Litmus Test

Generon in Shanghai was founded by former Hutchison MediPharma employees to target a niche market between expensive import drugs and lower quality domestic products.

BIO 2012 Spotlight: Discussions On Biosimilars, EMs, Partnerships And Global R&D

During BIO 2012 in Boston last week global pharma leaders discussed many topics related to emerging markets. PharmAsia News takes a closer look.

Related Content

UsernamePublicRestriction

Register

OM016808

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel